Research ArticleNEUROPHARMACOLOGY
A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 Receptor Antagonist, Dose-Dependently Reduces Neuropathic Pain in the Rat
Prisca Honore, Diana Donnelly-Roberts, Marian T. Namovic, Gin Hsieh, Chang Z. Zhu, Joe P. Mikusa, Gricelda Hernandez, Chengmin Zhong, Donna M. Gauvin, Prasant Chandran, Richard Harris, Arturo Perez Medrano, William Carroll, Kennan Marsh, James P. Sullivan, Connie R. Faltynek and Michael F. Jarvis
Journal of Pharmacology and Experimental Therapeutics December 2006, 319 (3) 1376-1385; DOI: https://doi.org/10.1124/jpet.106.111559
Prisca Honore
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Diana Donnelly-Roberts
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Marian T. Namovic
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Gin Hsieh
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Chang Z. Zhu
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Joe P. Mikusa
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Gricelda Hernandez
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Chengmin Zhong
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Donna M. Gauvin
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Prasant Chandran
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Richard Harris
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Arturo Perez Medrano
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
William Carroll
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Kennan Marsh
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
James P. Sullivan
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Connie R. Faltynek
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Michael F. Jarvis
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois

Log in using your username and password
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 368, Issue 3
1 Mar 2019
Research ArticleNEUROPHARMACOLOGY
A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 Receptor Antagonist, Dose-Dependently Reduces Neuropathic Pain in the Rat
Prisca Honore, Diana Donnelly-Roberts, Marian T. Namovic, Gin Hsieh, Chang Z. Zhu, Joe P. Mikusa, Gricelda Hernandez, Chengmin Zhong, Donna M. Gauvin, Prasant Chandran, Richard Harris, Arturo Perez Medrano, William Carroll, Kennan Marsh, James P. Sullivan, Connie R. Faltynek and Michael F. Jarvis
Journal of Pharmacology and Experimental Therapeutics December 1, 2006, 319 (3) 1376-1385; DOI: https://doi.org/10.1124/jpet.106.111559
Research ArticleNEUROPHARMACOLOGY
A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 Receptor Antagonist, Dose-Dependently Reduces Neuropathic Pain in the Rat
Prisca Honore, Diana Donnelly-Roberts, Marian T. Namovic, Gin Hsieh, Chang Z. Zhu, Joe P. Mikusa, Gricelda Hernandez, Chengmin Zhong, Donna M. Gauvin, Prasant Chandran, Richard Harris, Arturo Perez Medrano, William Carroll, Kennan Marsh, James P. Sullivan, Connie R. Faltynek and Michael F. Jarvis
Journal of Pharmacology and Experimental Therapeutics December 1, 2006, 319 (3) 1376-1385; DOI: https://doi.org/10.1124/jpet.106.111559